# Determinants of Warfarin Metabolism

> **NCT00162474** · NA · RECRUITING · sponsor: **Hadassah Medical Organization** · enrollment: 1000 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Warfarin
- **DRUG:** Phenytoin
- **DRUG:** Losartan & Hydrochlorothiazide
- **DRUG:** Flurbiprofen
- **DRUG:** Siponimod
- **DRUG:** Dicloxacillin

## Key facts

- **NCT ID:** NCT00162474
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2003-09
- **Primary completion:** 2030-12
- **Final completion:** 2030-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00162474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00162474, "Determinants of Warfarin Metabolism". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT00162474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*